What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients?
Lee
Kachiu C
KC
Department of Dermatology, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.
Risser
Jessica
J
Bercovitch
Lionel
L
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D000634:Aminoquinolines / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D004819:Epidermodysplasia Verruciformis / Q000188:drug therapy* / Q000209:etiology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000077271:Imiquimod; D008297:Male; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod